Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling. [electronic resource]
Producer: 20091130Description: 690-9 p. digitalISSN:- 1521-0103
- Animals
- Anti-Anxiety Agents
- Behavior, Animal -- drug effects
- Cells, Cultured
- Cyclic AMP -- metabolism
- Cyclic GMP -- physiology
- Enzyme Inhibitors -- pharmacology
- Exonucleases -- antagonists & inhibitors
- Guanylate Cyclase -- antagonists & inhibitors
- Imidazoles -- pharmacology
- Male
- Mice
- Mice, Inbred ICR
- NG-Nitroarginine Methyl Ester -- pharmacology
- Neurons -- drug effects
- Nitric Oxide Donors -- pharmacology
- Oxadiazoles -- pharmacology
- Phosphodiesterase Inhibitors -- pharmacology
- Quinoxalines -- pharmacology
- Rats
- Recombinant Proteins -- chemistry
- Signal Transduction -- drug effects
- Triazines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.